Vascular Intervention Strategies Trial for Alzheimer's

Starting soon · Phase 2

Conditions studied: Hypertension, Hypercholesterolemia, Dementia Risk Factors

In brief

The proposed pharmacist-led study is a feasibility pilot trial for the management of vascular risk factors of hypertension and hypercholesterolemia in 10 APOE ε4 carriers, 50-75, at-risk for dementia. All participants will receive angiotensin receptor blockers (ARBs) for high blood pressure, and hydrophilic statins (or a non-statin alternative) for high cholesterol over a six-month period.

Key facts

Study ID

NCT07447206

Run by

University of Southern California

People needed

10

Starts

2026-05-01

Expected to finish

2028-06-01

Last updated by the study team

2026-05-04

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• APOE ε4 carrier (homozygote or heterozygote)
• LDL-C of 100-250 mg/dL
• Systolic blood Pressure (SBP) 130-180 mm Hg
• Age 50-75 years
• Fluency in English
• No dementia based on medical record review
• Male or post-menopausal female

You may not qualify if…

• One minute standing SBP < 110 mm Hg
• Arm circumference prevents from accurate BP measurement with use of available devices
• Lost weight of > 10% unintendedly (within the past 6 months),
• Contraindications to blood pressure and cholesterol lowering medications
• Use of medications prescribed for dementia (e.g., aducanumab, donanemab, lecanemab, donepezil, galantamine, rivastigmine, memantine)
• Evidence of dementia based on medical record review
• Living in a skilled nursing or rehabilitation facility
• Receiving palliative or hospice care
• Bipolar illness or schizophrenia
• Drug or alcohol disorder
• Receiving chronic opioid therapy
• Any significant neurological disease (e.g., Parkinson's disease, amyotrophic lateral sclerosis, or multiple sclerosis)
• Severe loss of visual, hearing or communication ability
• Organ transplant
• History of stroke, symptomatic HF or left ventricular ejection fraction < 35%
• ESRD or eGFR < 20 ml/min /1.73m2
• Does not consent to be contacted or to have their medical record reviewed for research purposes
• Concurrent participation in another clinical trial

Where it is running

• Clinical Sciences Building (CSC) — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.